Uganda: World Bank Loans Were Tempting the Corrupt - IGG Kamya [Nile Post] The Inspector General of Government (IGG), Beti Olive Kamya has announced the inspectorates stringent measures already set to…
Hansa Biopharma half year report 2023 · Solid product sales in Q2 2023 · Collaboration announced in gene therapy with Genethon in Crigler-Najjar syndrome …
First patient treated with imlifidase in an investigator-initiated Phase 2 study in ANCA-associated vasculitis Lund, Sweden 19 July, 2023. Hansa Biopharma (“Hansa”), a pioneer in enzyme technology for rare immunological conditions, today announced first…
Game Developers Under Selling Pressure; IGG Collapses 21% HK-listed game developers broadly took on way more selling pressure than the general market today. IGG (00799.HK), underperforming the peers,…
Hansa Biopharma interim report January–March 2023 · Positive reimbursement decision in Spain expands market access to include the five largest European markets · Enrollment in…
argenx Demonstrates Commitment to Redefining Treatment Goals for Generalized Myasthenia Gravis with Multiple Presentations at American Academy of Neurology 2023 Annual Meeting Amsterdam, the Netherlands – [04/18/2023] argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives…
Gaming Stocks Develop Individually, IGG (00799.HK) Rockets 21% to Peak With High Trading Vol. Gaming Stock IGG (00799.HK) has strongly outperformed its peers, with shares rising for eight straight trading days, reaching peak at…
Hansa Biopharma Year-end report January-December 2022 · Total 2022 revenue of SEK 155m · Cash runway extended into 2025 · Market Access obtained in…
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease Next-generation IgG protease candidate Xork to be licensed for development with AT845, an investigational Astellas Gene Therapies product, for the…